Chemical Price | Prices | Pricing | Monitoring | ChemAnalyst

For the Quarter Ending September 2023 North America: Throughout the third quarter of 2023,  Carbamazepine API prices  in North America mirrored the market trends observed in the APAC region. July saw prices remaining on the pessimistic side, but as Q3 progressed, there was a moderate rise in demand from the healthcare sector. Despite elevated Carbamazepine inventory levels in the local spot market, merchants aimed to meet arriving requirements. Moving into August, prices steadily increased, with manufacturers acquiring materials based on orders, ensuring a consistent Carbamazepine flow. However, surges in shipping costs and rising raw material (Acetic acid) prices deterred additional orders. The continuous increase in energy and fuel costs further contributed to the Carbamazepine price rise until the end of September. Asia Pacific: In the APAC region, especially in the Indian market, Carbamazepine API prices sustained a weaker trajectory in the first half of Q3 2023. This was ...

For the Quarter Ending June 2023 North America: Carbamazepine prices  in North America started on an optimistic note but ended on a pessimistic trend in the second quarter of 2023. The prices followed the market trend in India throughout the quarter, gradually increasing from the previous month until May 2023. This rise in prices was driven by improved demand in the pharmaceutical and healthcare industries, allowing retailers to charge higher prices. Despite the strengthening Consumer Price Index (CPI) in the US, prices for Carbamazepine sharply decreased as June approached. Local demand also saw a sharp decline, and analysts suggested that there was still significant underlying inflation despite falling energy prices. Asia Pacific: In the Asia Pacific region, Carbamazepine prices showed a descending pricing sentiment throughout the second quarter of 2023. Prices dropped considerably in April, indicating a positive demand outlook until mid-Q2. However, prices sharply decreased as Q...

For the Quarter Ending June 2023 North America: Carbamazepine prices  in the North American region embarked optimistically but concluded pessimistically in the second quarter of 2023. These prices followed a trend similar to that of the Indian market throughout the quarter. Initially, prices gradually increased from the previous month at the quarter's start, holding up until mid-Q2, around May 2023. The rise in Carbamazepine prices stemmed from heightened demand in the pharmaceutical and healthcare industries, benefiting retailers by allowing them to charge higher prices. The Consumer Price Index (CPI) in the US also experienced growth, rising by 0.6% in May 2023 after a 0.3% increase in April. This contributed to the optimistic market trend for Carbamazepine in the US. Additionally, the energy index showed a 3.9% increase. However, prices for Carbamazepine sharply declined as June approached, despite the strengthening CPI, which rose by 0.1% from May to June 2023. Local demand wit...